Liraglutide (204656-20-2)
Productoverzicht
Liraglutide (204656-20-2) is een GLP-1-receptoragonist voor diabetes type 2 en gewichtsbeheersing. Beschikt over glucose-afhankelijke insulinesecretie, controle van de eetlust en cardiovasculaire bescherming. Wit poeder bewaard bij -20°C. Voor R&D-gebruik.
Product aangepaste attributen
Productbeschrijving
Liraglutide is an artificially synthesized glucagon-like peptide-1 (GLP-1) receptor agonist, mainly used for the treatment of type 2 diabetes and long-term weight management.
Mechanism of action:
- Blood sugar regulation: Stimulates insulin secretion in a glucose concentration-dependent manner, while reducing glucagon secretion, thereby lowering blood sugar levels.
- Weight control: By delaying gastric emptying and acting on specific areas of the brain to control appetite and food intake, it increases satiety.
- Cardiovascular protection: Has multiple protective effects on the cardiovascular system, including lowering systolic blood pressure.
*The product under patent is only for R&D use.
Neem contact op met onze experts en krijg een gratis consult!
Onze missie is om "High Quality" & "Good Service" & "Fast Delivery" aan te bieden om onze klanten te helpen meer winst te maken.
